🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMetabolic Health & DiabetesPost-prandial glucose control — GLP-1 vs DPP-4 vs SGLT2i comparison Page 5

Post-prandial glucose control — GLP-1 vs DPP-4 vs SGLT2i comparison

SarahChen_PharmD Thu, May 28, 2026 at 8:19 PM 21 replies 573 viewsPage 5 of 5
hank_denver
Member
278
1,234
Sep 2024
Denver, CO
May 29, 2026 at 3:24 AM#21

+1 to TirzTom. Especially the point about "Saving this for reference..." — I have seen the same in my own experience with Post-prandial glucose.

8 9ingrid_STO, pete_nash, hank_denver and 5 others
Reply Quote Save Share Report
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
May 29, 2026 at 3:41 AM#22

Subscribing to this thread. Post-prandial glucose is exactly what I've been researching. 🙏

7 5stefan_berlin, Dr.EM_Chicago, pete_RVA and 4 others
Reply Quote Save Share Report
TomTeleRx
Member
189
678
Feb 2025
Delaware
May 29, 2026 at 3:58 AM#23

+1 to hyun_seoul. Especially the point about "" — I have seen the same in my own exper..." — I have seen the same in my own experience with Post-prandial glucose.

31 10LibrarianMeg, bri_stats, pete_manc_UK and 28 others
Reply Quote Save Share Report
JessicaM_2024
Member
823
3,456
Mar 2024
Portland, OR
May 29, 2026 at 4:15 AM#24

Yep. My endo said the same thing about Post-prandial.

13 12Dr.PainCLE, mike_mealprep, NicoleRaleigh and 10 others
Reply Quote Save Share Report
jennifer_SEA
Member
234
890
Nov 2024
Seattle, WA
May 29, 2026 at 4:32 AM#25

Slightly tangential to Post-prandial glucose but TrialTracker_MD reminded me — has the insurance landscape changed recently?

I know it is not exactly on-topic but it seems related enough to ask here rather than starting a new thread. Apologies if this has been covered — I did search first.

Last edited: May 29, 2026 at 10:32 AM
42 23hyun_seoul, jim_asheville, matt_MKE and 39 others
Reply Quote Save Share Report
1345

Similar Threads

SUSTAIN-6 to SELECT — the cardiovascular evidence timeline14 replies
GLP-1 and insulin resistance — HOMA-IR improvement data17 replies
Metabolic syndrome reversal criteria — how GLP-1 addresses all 55 replies
A1C target achievement rates — sema vs tirz comparison8 replies
SURPASS-CVOT: tirzepatide cardiovascular outcomes trial design3 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register